Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Pharmacokinetics-Pharmacodynamics (PK-PD) Profile, Effectiveness and Safety of ATM-AVI in Special Populations
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Impact of Rapid Diagnostic Tests (RDTs) on Treatment Pattern and Outcomes in Patients with Carbapenem-Resistant (CR) Pathogens
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Initiatives to Improve the Clinical Environment for Dermatologic Immunology, Inflammation, and Allergy Care
    Release Date:
    Partner: The Japanese Society for Cutaneous Immunology and Allergy
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Inflammation & Immunology Japan
    Real World, Long-term Efficacy Study of Ritlecitinib in Adult and Adolescent Patients with Severe Alopecia Areata in China
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Epidemiology and surveillance of Gram-negative infections caused by carbapenemase-producing organisms (CPOs) in the UK
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine United Kingdom
    Advancing Care for Patients with Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC)
    Release Date:
    Partner: ALK Positive
    Review Process: Pfizer Internal
    Education Oncology All
    Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache Disorders
    Release Date:
    Partner: American Headache Society
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine Canada, USA
    Shared Decision Making in Hemophilia Patient Care
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease China
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    2021 Ulcerative Colitis Competitive Grant Program
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology USA
    Adoption of Biosimilars in Oncology
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology Canada
    2021 Global Hemophilia ASPIRE
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease All
    Inflammatory and Immune-Mediated Dermatologic Disorders
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology USA
    Advances in Atopic Dermatitis & Alopecia Areata for Community Pharmacists & Managed Care Health Care Professionals
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Understanding Residual Cardiovascular Risk Related to Triglyceride-Rich Remnant Lipoproteins
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine All
    Call for Independent Medical Education Grant Applications Oncology – Prostate Cancer
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology USA
    I&I REALE 2021 RhEumatoid Arthritis Italian ReaL World Experience
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology Italy
    2021 Rheumatology Fellowship
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology USA
    2021 Inflammatory Bowel Disease (IBD) Fellowship
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology USA
    Inflammatory and Immune-Mediated Dermatologic Disorders (Global excluding U.S.)
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology All
    2021 Fellowship for Inflammatory Dermatological Diseases
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology USA